Author

Ariful Islam

University of PennsylvaniaPrimary ORCID profile (0000-0001-7497-3540 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Ariful IslamiD1 paper · North South University

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Research Focus:differential expression· 2 Organism:rat· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Alexey GurevichiD· 2 shared David P. CormodeiD· 2 shared Terence P.F. GadeiD· 2 shared Eva Yarsky· 1 shared G. J. NadolskiiD· 1 shared George McClungiD· 1 shared Jonathan WakimiD· 1 shared Kathleen Elizabeth Villaseñor· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Alexey GurevichORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Quantifying the Provenance-to-Function Gap in Antidiabetic Peptide Prediction: Homology-Aware Evaluation and the ADP-Hybrid Baseline

Ariful ISLAM, Md. Faruk Hosen, Md. Abul Basar, Mohammad Sarwar Hossain Mollah, Muhammad Shahin Uddin

The paper evaluates the provenance-to-function gap in antidiabetic peptide prediction by re-evaluating benchmarks with homologous peptide grouping and introduces the ADP-Hybrid baseline classifier.

bioRxiv · Oct 1, 2026 · PreprintBioinformatics

Drug-Eluting, Radiopaque, Tumor-Casting Hydrogels for Endovascular Locoregional Therapy of Hepatocellular Carcinoma

Yuxi C. Dong, Kathleen Elizabeth Villaseñor, Seokyoung Yoon, Ariful Islam, Luis Vazquez, Alexey Gurevich, Shaun W. McLaughlin, Terence P.F. Gade, David P. Cormode

This study develops a hydrogel for treating hepatocellular carcinoma that improves embolization and drug delivery, showing better tumor growth reduction than standard treatments.

bioRxiv · Nov 25, 2025 · PreprintCancer Biology

Transarterial Embolization Using a Liquid Embolic Enhances Tumor Necrosis to Enable Improved Efficacy Compared with a Particle Embolic in a Translational Rat Model of Hepatocellular Carcinoma

Alexey Gurevich, Ariful Islam, Jonathan Wakim, Eva Yarsky, Ryan M. Kiefer, Ryan El Ghazal, George McClung, David P. Cormode, G. J. Nadolski, Rony Avritscher, Stephen James Hunt, Terence P.F. Gade

This study compares liquid embolic (LE) and particle embolic (PE) in transarterial embolization (TAE) for hepatocellular carcinoma (HCC) in rats, finding LE induces greater tumor necrosis and improved treatment response.

bioRxiv · May 23, 2024 · PreprintCancer Biology